{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Enliven Therapeutics, Inc. "},"Symbol":{"label":"Symbol","value":"ELVN"},"Address":{"label":"Address","value":"1111 MELVILLE STREET,SUITE 1100, VANCOUVER, British Columbia, V6E 3V6, Canada"},"Phone":{"label":"Phone","value":"+1 604 377-5781"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer. The Company focuses on addressing existing and emerging unmet needs with a precision oncology approach. The Company is advancing two parallel lead product candidates, ELVN-001 and ELVN-002, as well as pursuing several additional research stage opportunities. Its first product candidate, ELVN-001, is a potent, highly selective, small molecule kinase inhibitor designed to specifically target the breakpoint cluster region-Abelson (BCR-ABL) gene fusion, the oncogenic driver for patients with chronic myeloid leukemia (CML). Its second product candidate, ELVN-002, is a potent, selective, and irreversible human epidermal growth factor receptor 2 (HER2) inhibitor with activity against various HER2 mutations, including Exon 20 insertion mutations (E20IMs) in non-small cell lung cancer (NSCLC)."},"CompanyUrl":{"label":"Company Url","value":"https://www.enliventherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anish Patel","title":"Chief Operating Officer"},{"name":"Helen Collins","title":"Chief Medical Officer"},{"name":"Joseph P. Lyssikatos","title":"Chief Scientific Officer"},{"name":"Samuel S. Kintz","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}